BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21648076)

  • 1. Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles.
    Yu MK; Kim D; Lee IH; So JS; Jeong YY; Jon S
    Small; 2011 Aug; 7(15):2241-9. PubMed ID: 21648076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
    Yu MK; Park J; Jeong YY; Moon WK; Jon S
    Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.
    Lee H; Yu MK; Park S; Moon S; Min JJ; Jeong YY; Kang HW; Jon S
    J Am Chem Soc; 2007 Oct; 129(42):12739-45. PubMed ID: 17892287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
    Kim E; Jung Y; Choi H; Yang J; Suh JS; Huh YM; Kim K; Haam S
    Biomaterials; 2010 Jun; 31(16):4592-9. PubMed ID: 20206379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging.
    Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC
    J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.
    Jalalian SH; Taghdisi SM; Shahidi Hamedani N; Kalat SA; Lavaee P; Zandkarimi M; Ghows N; Jaafari MR; Naghibi S; Danesh NM; Ramezani M; Abnous K
    Eur J Pharm Sci; 2013 Oct; 50(2):191-7. PubMed ID: 23835028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.
    Maeng JH; Lee DH; Jung KH; Bae YH; Park IS; Jeong S; Jeon YS; Shim CK; Kim W; Kim J; Lee J; Lee YM; Kim JH; Kim WH; Hong SS
    Biomaterials; 2010 Jun; 31(18):4995-5006. PubMed ID: 20347138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers.
    Min K; Jo H; Song K; Cho M; Chun YS; Jon S; Kim WJ; Ban C
    Biomaterials; 2011 Mar; 32(8):2124-32. PubMed ID: 21147500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary toxicity and kinetic study of Cy5.5-conjugated superparamagnetic iron oxide nanoparticles by optical imaging.
    Cho WS; Cho M; Kim SR; Choi M; Lee JY; Han BS; Park SN; Yu MK; Jon S; Jeong J
    Toxicol Appl Pharmacol; 2009 Aug; 239(1):106-15. PubMed ID: 19520096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer-assisted superparamagnetic iron oxide nanoparticles as multifunctional drug delivery platform for chemo-photodynamic combination therapy.
    Sun X; Liu B; Chen X; Lin H; Peng Y; Li Y; Zheng H; Xu Y; Ou X; Yan S; Wu Z; Deng S; Zhang L; Zhao P
    J Mater Sci Mater Med; 2019 Jun; 30(7):76. PubMed ID: 31218573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment.
    Cho HS; Dong Z; Pauletti GM; Zhang J; Xu H; Gu H; Wang L; Ewing RC; Huth C; Wang F; Shi D
    ACS Nano; 2010 Sep; 4(9):5398-404. PubMed ID: 20707381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
    J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmaceutical study of doxorubicin-loaded PEGylated nanoparticles for magnetic drug targeting.
    Gautier J; Munnier E; Paillard A; Hervé K; Douziech-Eyrolles L; Soucé M; Dubois P; Chourpa I
    Int J Pharm; 2012 Feb; 423(1):16-25. PubMed ID: 21703340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
    Nagesh PKB; Johnson NR; Boya VKN; Chowdhury P; Othman SF; Khalilzad-Sharghi V; Hafeez BB; Ganju A; Khan S; Behrman SW; Zafar N; Chauhan SC; Jaggi M; Yallapu MM
    Colloids Surf B Biointerfaces; 2016 Aug; 144():8-20. PubMed ID: 27058278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
    Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
    Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-responsive multifunctional magnetic nanoparticles for tumor intracellular drug delivery and imaging.
    Yang Y; Aw J; Chen K; Liu F; Padmanabhan P; Hou Y; Cheng Z; Xing B
    Chem Asian J; 2011 Jun; 6(6):1381-9. PubMed ID: 21548100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
    He X; Hai L; Su J; Wang K; Wu X
    Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
    Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
    Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
    Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
    Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.